GLP-1 Medications and Gastroparesis: What to Know
GLP-1s slow stomach emptying by design. Here is the honest safety picture.
The short answer
GLP-1 medications slow gastric emptying on purpose, that delayed emptying is part of how they reduce appetite. In most people this is mild and improves over time. Rarely, it can be more pronounced, and there have been reports of severe delayed emptying (sometimes described as gastroparesis-like). Screening and supervision matter.
Who needs extra caution
People with a known history of gastroparesis or significant gastrointestinal motility problems need careful evaluation before starting, and sometimes a different approach. This is exactly the kind of history a physician screens for, which is why a real medical review, not a quick online form, is the safe path.
Ready to start?
$199 Skeptics’ Trial, see if it works for you
One month of medical-grade compounded semaglutide, the $119 doctor review, and a free B-12/lipotropic injection. No long-term commitment.
Start the 30-day trialWarning signs to report
Persistent vomiting, severe or ongoing abdominal pain, inability to keep food or fluids down, or feeling full long after eating should be reported to your clinician promptly. Slower, careful dose titration and good hydration reduce risk. Tell your care team and any surgical or anesthesia team that you take a GLP-1.
How this relates to what we offer
Every plan starts with a $119 physician review that screens your history and contraindications, and we titrate carefully with follow-up rather than handing out a fixed dose.
What you can start today at New Hope Weight Loss
After a one-time $119 medical review with Dr. Sharma, eligible patients begin physician-supervised compounded semaglutide from $166 a month or compounded tirzepatide from $233 a month, with a $199 one-month Skeptics' Trial. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality. In person in Orange County and by telehealth across California and additional states.
Frequently asked questions
Can GLP-1 medications cause gastroparesis?
GLP-1s slow gastric emptying by design, which is usually mild. Rarely, severe delayed emptying has been reported. People with a history of motility problems need careful evaluation before starting.
What are the warning signs?
Persistent vomiting, severe or ongoing abdominal pain, inability to keep food or fluids down, or prolonged fullness after eating. Report these to your clinician promptly.
Should I tell my surgeon I take a GLP-1?
Yes, always. Delayed stomach emptying can matter for anesthesia and procedures. Tell any surgical or anesthesia team in advance so they can plan safely.
How is the risk reduced?
Careful, slower dose titration, good hydration, physician screening for motility history, and prompt reporting of symptoms all lower risk. Supervision is key.
Does New Hope screen for this?
Yes. The $119 review screens your history and contraindications, and we titrate carefully with follow-up rather than issuing a fixed dose.
This article is informational only and not medical advice. Speak with a licensed physician before starting or changing any GLP-1 therapy. Individual results vary. New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, CA. Eligibility for treatment is determined during the medical consultation. Compounded semaglutide and compounded tirzepatide are not the same products as Wegovy®, Ozempic®, Mounjaro®, or Zepbound®.